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OBJECTIVES: There already exists an algorithm to 
generate utility scores from SF-36 data. This has a serious
ﬂoor affect and does not accurately describe EQ-5D data.
The purpose of this study was to develop an alternative
model that better accommodates utility scores from the
entire range of ill-health. METHODS: Data on 1946
inpatients and outpatients were abstracted from the
Health Outcomes Data Repository (HODAR) in Cardiff,
UK and utilised in the model building. Validation of 
the model was made using independent data from 554
respondents from a survey of people with diabetes in
Cardiff that included the EQ-5D, SF-36. Both surveys
also included complete inpatient records, diagnoses, 
procedures, in and out of hospital mortality, biochemi-
stry, unit costs, inpatient medications, risk factors and
demography. Various multivariate parametric and non-
parametric techniques were applied to calculate an opti-
mised model on the HODAR data set. RESULTS: When
applied to the diabetes data, the calculated and actual
values were as follows. Data are the minimum and
maximum utility values, the inter-quartile range, median,
mean, and standard deviation, respectively. Results from
the survey were as follows: -0.48, 1, 0.52, 0.85, 0.71,
0.65 and 0.32, respectively. For the existing model, 0.26,
1, 0.61, 0.85, 0.74, 0.72 and 0.16, respectively. For the
revised model, 0.05, 1, 0.52, 0.94, 0.76, 0.71 and 0.25,
respectively. CONCLUSION: This new algorithm repre-
sents a notable improvement on the existing model.
Proper evaluation of new medicines is vital, and the ﬂoor
effect tends to reduce incremental cost utility ratios when
achieving certain thresholds is important for drug reim-
bursement. HODAR will evolve to be the largest series of
outcome data anywhere.
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OBJECTIVES: To examine systematically the Childhood
Health Assessment Questionnaire (CHAQ) for use in
non-arthritic populations and to assess its sensitivity 
to effects observed in clinical trials of drug treatments.
METHODS: A primary computerized literature search
(1966-present) identiﬁed English-language publications
with the term, “CHAQ”. Supplemental searches were
conducted to identify use of CHAQ in clinical studies of
speciﬁc juvenile arthropathies for comparisons. Manual
searches were also conducted from the bibliographies of
the articles retrieved. Articles were selected for detailed
review if they met speciﬁc criteria related to the CHAQ’s
development and use. Articles were examined with
respect to study type, country, patient population, psy-
chometric validity in a speciﬁed patient population, and
correlations with objective clinical measures, such as joint
range of motion. RESULTS: Of 237 abstracts reviewed,
59 articles met the selection criteria for detailed review.
Roughly three-quarters of the CHAQ articles were cross-
cultural adaptation and validation studies for countries
outside the U.S. The CHAQ has been utilized to measure
disability and functional status in patients with juvenile
rheumatoid arthritis, juvenile spondyloarthropathy, spina
biﬁda, juvenile idiopathic inﬂammatory myopathies, 
and juvenile onset mixed connective tissue disease. The
CHAQ correlated with several joint range of motion 
measurements and scales (e.g. EPM-ROM, JAM, and
GROMS), although there is some concern regarding the
sensitivity of these other instruments. Few observational
studies have used the CHAQ, and only one study using
the CHAQ was a randomized clinical trial. CONCLU-
SIONS: The CHAQ appears valuable in measuring dis-
ability and functional status in populations for which 
it was developed and validated (i.e. juvenile arthritis),
although additional research is needed to determine the
instrument’s ability in assessing sensitivity to change in
drug therapies before use in non-arthritic populations.
Future studies should be undertaken to provide empirical
evidence of its reliability in populations for which the
CHAQ has not been validated.
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OBJECTIVES: The Short-Form 36 (SF-36) is a widely
used measure providing scores for 8 domains of health
status. Recently Brazier et al. created the SF6D system
that covers 6 of the 8 domains and provides single-
summary utility scores. The ﬁrst objective is to compare
6D, standard gamble (SG), Health Utilities Index Mark 2
(HUI2), and HUI Mark 3 (HUI3) scores. The second
objective is to compare the change between pre- and post-
surgery. The third objective is to compare the respon-
siveness of the 4 utility measures. METHODS: A cohort
of patients referred for evaluation for total hip arthro-
plasty (THA) were evaluated at the time of referral and
followed until 3 months after THA. Patients were
assessed with the SF-36, HUI2, HUI3, the SG, and spe-
ciﬁc measures. Agreement is assessed using the intra-class
correlation (ICC). Responsiveness is assessed using effect
size, standardized response mean, and paired sample 
t-test. RESULTS: Complete data was available for 86
patients at baseline and for 63 at both pre- and post-
surgery. At baseline mean 6D (0.61), SG (0.62), and HUI2
(0.62) scores were similar; HUI3 (0.52) was lower. There
was less variability in 6D scores; standard deviation of
0.10 compared to 0.32 for SG, 0.19 for HUI2, and 0.22
